Langhorne, PA, United States of America

John R Wetterau, Ii



Average Co-Inventor Count = 3.1

ph-index = 5

Forward Citations = 307(Granted Patents)


Company Filing History:


Years Active: 1997-2002

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of John R Wetterau, II

Introduction

John R Wetterau, II is a notable inventor based in Langhorne, Pennsylvania. He has made significant contributions to medical science through his innovative inventions, particularly in the fields of triglyceride transfer and lipase deficiency treatments. With a total of five patents to his name, Wetterau continues to impact the landscape of therapeutic agents.

Latest Patents

Wetterau's latest patents involve critical advancements in understanding and treating conditions related to microsomal triglyceride transfer proteins. One of his prominent inventions includes nucleic acid sequences, particularly DNA sequences, that code for the high molecular weight subunit of microsomal triglyceride transfer protein. His work with expression vectors and host cells related to these DNA sequences has opened new avenues for research and treatment strategies. Additionally, his invention introduces novel methods aimed at preventing and stabilizing atherosclerosis, as well as therapeutic agents that facilitate these outcomes. Another notable patent focuses on a method for treating acid lipase deficiency diseases through the use of an MTP inhibitor, showcasing his dedication to addressing and resolving significant health issues.

Career Highlights

Throughout his career, Wetterau has been affiliated with reputable organizations such as Bristol-Myers Squibb Company and E.R. Squibb & Sons, Inc. His roles in these companies have allowed him to collaborate with other leading professionals in the field, enhancing his ability to innovate and contribute to medical advancements.

Collaborations

Wetterau has worked alongside distinguished colleagues, including Richard E Gregg and Daru Young Sharp. These collaborations have proved instrumental in the development and refinement of his inventions, showcasing the importance of teamwork in the pioneering of medical technology.

Conclusion

John R Wetterau, II exemplifies the spirit of innovation in the realm of medical inventions. His patents represent significant strides in addressing health complications related to triglyceride transfer and acid lipase deficiency. With a continued commitment to research and collaboration, Wetterau's work promises to enhance therapeutic options for patients and contribute to the broader medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…